Skip to content
10-Q

Quarterly Report

CARDIFF ONCOLOGY, INC. CRDF

0001213037-26-000011

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 68.37M sh
Shares Diluted Q1 2026 · Mar 31, 2026 68.35M sh
Shares Diluted Q1 2026 · Mar 31, 2025 66.52M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$12.29M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$12.79M
Short Term Investments Q1 2026 · Mar 31, 2026 $37.51M
Short Term Investments Q1 2026 · Dec 31, 2025 $40.83M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $8.54M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17.47M
Stockholders Equity Q1 2026 · Mar 31, 2026 $34.71M
Stockholders Equity Q1 2026 · Dec 31, 2025 $45.39M
Stockholders Equity Q1 2026 · Mar 31, 2025 $70.88M
Stockholders Equity Q1 2026 · Dec 31, 2024 $82.95M
Current Liabilities Q1 2026 · Mar 31, 2026 $14.46M
Current Liabilities Q1 2026 · Dec 31, 2025 $16.39M
Total Liabilities Q1 2026 · Mar 31, 2026 $14.46M
Total Liabilities Q1 2026 · Dec 31, 2025 $16.5M
Current Assets Q1 2026 · Mar 31, 2026 $47.34M
Current Assets Q1 2026 · Dec 31, 2025 $60.13M
Total Assets Q1 2026 · Mar 31, 2026 $49.17M
Total Assets Q1 2026 · Dec 31, 2025 $61.88M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.18
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.20
Eps Basic Q1 2026 · Mar 31, 2026 −$0.18
Eps Basic Q1 2026 · Mar 31, 2025 −$0.20
Sga Expense Q1 2026 · Mar 31, 2026 $6.13M
Sga Expense Q1 2026 · Mar 31, 2025 $4.01M
Net Income Q1 2026 · Mar 31, 2026 −$12.35M
Net Income Q1 2026 · Mar 31, 2025 −$13.43M
Operating Income Q1 2026 · Mar 31, 2026 −$12.85M
Operating Income Q1 2026 · Mar 31, 2025 −$14.38M
Revenue Q1 2026 · Mar 31, 2026 $41K
Revenue Q1 2026 · Mar 31, 2025 $109K